Inventor
WANG GUOCHENG
CN15 patents
⚠️ This page may combine multiple inventors who share the name “WANG GUOCHENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD
11 patentsUS12486259B2Dec 2, 2025
FXR agonist having pyrazine structure, and preparation method and use
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD0 citations59
US11149016B2Oct 19, 2021
S-substituted-2-amino-3-mercaptopropionate derivative, preparation method and application thereof
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD0 citations57
US11130766B2Sep 28, 2021
Deuterated thienopiperidine derivatives, manufacturing method, and application thereof
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD0 citations54
US10745434B2Aug 18, 2020
Uridine phosphoramide prodrug, preparation method therefor, and medicinal uses thereof
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD0 citations49
US10233202B2Mar 19, 2019
Tenofovir monobenzyl ester phosphamide prodrug, preparation method and use thereof
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD0 citations49
US10253007B2Apr 9, 2019
Taxanes compounds, preparation method therefor, and uses thereof
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD0 citations47
US9890175B2Feb 13, 2018
Taxane compound, and preparation method and use thereof
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD0 citations47
US9714250B2Jul 25, 2017
Crystalline forms of temozolomide and the method for preparing same
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD0 citations45
US10005757B2Jun 26, 2018
Revaprazan hydrochloride polymorphs and preparation method therefor
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD0 citations42
US10358449B2Jul 23, 2019
Xanthine derivative
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD0 citations31
US9981917B2May 29, 2018
Preparation method for revaprazan hydrochloride
JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD0 citations28